StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

PRAXBullishAnalyst Target Updateanalyst
Medium materiality6/10

Guggenheim Raises Praxis Precision Medicines Price Target to $1,050

Nov 16, 2026, 12:05 PM EST1 sourcesAI-analyzed
Why it may matterVerify against the original reporting

The large target increase is a bullish analyst signal, but the unusually high target warrants caution.

AI summary

What happened, with direct paths to the underlying reporting

Guggenheim raised its price target on PRAX to $1,050; the posted price was $328.13. The target implies substantial upside, though it is an analyst opinion rather than a guarantee.

  • Guggenheim raised its PRAX price target to $1,050.
  • Posted price: $328.13.

Key facts

  1. 01

    Target: $1,050

  2. 02

    Posted price: $328.13

  3. 03

    Analyst firm: Guggenheim

  4. 04

    Analyst: Yatin Suneja

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.